Tarsus Pharmaceuticals, Inc. Quarterly Costs and Expenses in USD from Q3 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Tarsus Pharmaceuticals, Inc. quarterly Costs and Expenses history and growth rate from Q3 2021 to Q3 2024.
Tarsus Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $73.3M, a 71.2% increase year-over-year.

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024		$73.3M	+$30.5M	+71.2%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-13
Q2 2024		$74.1M	+$41.3M	+126%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024		$65.3M	+$37.8M	+138%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q3 2023		$42.8M	+$19.9M	+86.9%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-13
Q2 2023		$32.8M	+$12.3M	+60.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023		$27.5M	+$7.39M	+36.8%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q3 2022		$22.9M	+$5.96M	+35.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022		$20.5M			Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022		$20.1M			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q3 2021		$16.9M			Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.